[G20-21] Brigatinib (non-small cell lung cancer) - Addendum to Commission A20-42

Last updated 15.10.2020

Project no.:
G20-21

Commission:
Commission awarded on 10.09.2020 by the Federal Joint Committee (G-BA).

Report type:
Addendum

Status:
Commission completed

Department/Division:
Health Economics

Application field:
Cancer

Note:

If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.

Contact

Info Service

Subscribe to daily updated information on projects, calls for tender, and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.